We describe a simple liquid-chromatographic assay of urinary 4-hydroxy-3-methoxymandelic (vanillylmandelic) acid, 4-hydroxy-3-methoxypheny$acetic (homovanillic) acid, and 5-hydroxy-3-indoleacetic acid with electrochemical detection, with direct injection of the sample. The first two analytes are measured simultaneously; 5-hydroxy-3-indoleacetic acid is measured separately. Chromatographic conditions for assay of the three were: column temperature, 65 and 60 #{176}C; mobile phase, potassium phosphate buffer (0.2 molIL, pH 3.0) for 6 mm, then potassium phosphate buffer plus acetonitrile (9/1 by vol) for 20 mm; flow rate, 0.7 mL'min; oxidation potential, 600 and 450 mV vs an Ag/AgCI reference electrode; and sensitivity, 40 and 160 nA at full scale. Values so obtained agreed well with those obtained for samples that were first solvent-extracted.
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We describe a simple liquid-chromatographic assay of urinary 4-hydroxy-3-methoxymandelic (vanillylmandelic) acid, 4-hydroxy-3-methoxypheny$acetic (homovanillic) acid, and 5-hydroxy-3-indoleacetic acid with electrochemical detection, with direct injection of the sample. The first two analytes are measured simultaneously; 5-hydroxy-3-indoleacetic acid is measured separately. Chromatographic conditions for assay of the three were: column temperature, 65 and 60 #{176}C; mobile phase, potassium phosphate buffer (0.2 molIL, pH 3.0) for 6 mm, then potassium phosphate buffer plus acetonitrile (9/1 by vol) for 20 mm; flow rate, 0.7 mL'min; oxidation potential, 600 and 450 mV vs an Ag/AgCI reference electrode; and sensitivity, 40 and 160 nA at full scale. Values so obtained agreed well with those obtained for samples that were first solvent-extracted.
Additional Keyphrases: pheochromocytoma neuroblastoma carcinoid syndrome reference interval screening
Urinary 4-hydroxy-3-methoxymandelic (vanillylmandelic) acid (VMA)3 and 4-hydroxy-3-methoxyphenylacetic (homovanillic) acid (HVA), the major metabolic end products of norepinephrine/epinephrine and dopamine, respectively, are measured as an aid in diagnosis of patients with pheochromocytoma or neuroblastoma. Urinary excretion of 5-hydroxy-3-indoleacetic acid (5-HIAA), a main metabolite of serotonin, is increased in patients with carcinoid syndrome.
Generally, VMA (1) and 5-HIAA (2) are measured colonmetrically and HVA (3) by gas chromatography; however, these methods require solvent extraction and derivatization.
"High-performance" liquid chromatography with electrochemical detection has been successfully applied in analysis for catecholamines and their metabolites (4, 5). Urinary VMA (6), HVA (7), and 5-HIAA (8) have also been determined by liquid chromatography with electrochemical detection. Each compound was separated by liquid chromatography under different conditions and assayed individually with electrochemical detection. HVA could be detected by injecting diluted urine directly into a reversed-phase column and monitoring with electrochemical detection (7), but electrochemical detection of urinary VMA and 5-HIAA by direct sample injection was not feasible because of the numerous interfering compounds in urine (6, 8) Here we describe a simple, rapid procedure for simultaneous analysis for VMA and HVA, and analysis for 5-HIAA, by injecting urine directly into a reversed-phase column and monitoring the effluent with an electrochemical detector.
Materials and Methods

Instrumentation.
The "high-performance" liquid-chromatographic system (all from Yanaco, Kyoto, Japan) consisted of a Model L-2000 chromatograph with an S.P. 2000-GS solvent-gradient former, an LA-100 column oven, and a 25 cm x 0.4 cm (i.d.) column packed with Yanapak ODS-T (average particle diameter 10 tim). The effluent was monitored with a glassy carbon electrode cell (Yanaco VMD-101).
Procedures.
From a 24-h urine specimen collected in the presence of 10 mL of 6 mol/L hydrochloric acid, centrifuge an aliquot at 9000 x g for 5 mm, and directly inject 5 .tL of the supernate into the column.
Different urines may have different interfering substances.
To obtain typical chromatograms,
we used "Q- we mixed a 200-pL aliquot of the acidified 24-h urine with 750 L of ethyl acetate by vortex-mixing for 30 s in 1.5-mL tubes, then centrifuging the tubes at 9000 x g to separate the two layers. After transferring 600 L of the ethyl acetate (top) layer to a small tube, we re-extracted the aqueous (bottom) layer with 500 sL of ethyl acetate, combined the ethyl acetate extracts, and evaporated them at room temperature under a stream of nitrogen. The residue in the tube was reconstituted with 200 1zL of the mobile phase, and a 5-FL aliquot was injected into the column.
For the simultaneous analysis for VMA and HVA, we used the following chromatographic conditions: column temperature, 65#{176}C; the first mobile phase, potassium phosphate buffer (0.2 mol/L, pH 3.0) for 6 mm, and the second mobile phase, buffer plus acetonitrile (9/1, by vol), for 20 mm; flow rate, 0.7 mL/min; oxidation potential, 600 mV vs an Ag/ AgCI reference electrode; sensitivity, 40 and 160 nA at full scale.
Chromatographic conditions for the assay of 5-HIAA were: column temperature, 60 #{176}C; mobile phase, the potassium phosphate buffer containing acetonitrile; flow rate, 0.7 mL'min; oxidation potential, 450 mV vs an Ag/AgCl reference electrode; and sensitivity, 40 and 160 n.A at full scale. of the acidified but otherwise untreated urine. Assay of VMA and HVA in one sample was complete in 40 ruin. Peak height was linearly related to the amounts of VMA and HVA injected from 5 to 100 ng.
Results and Discussion
The separation of urinary 5-HIAA, either by direct urine injection or after solvent extraction, is illustrated in Figure   2 . The retention time for 5-HIAA was 10.5 mm, and assay of one sample was complete in 15 mm. Peak height was linearly related to the amounts of 5-HIAA from 0.5 to 30 ng. The glassy carbon electrode was set at relatively low voltages, so as to give minimal signal for interfering peaks.
The reproducibility of the method is summarized in Table  1 .
In Figure 3 we compare VMA, HVA, and 5-HLAA values by direct urine injection (x) and after solvent extraction (y) for 25 urine samples from adult normal subjects. The respective values for VMA, HVA, and 5-HIAA were similar by the two methods. The respective normal reference intervals for urinary VMA, HVA, and 5-HIAA, based on values for these 25 adults, were 0.4-5.5, 0.7-6.9, and 0. 1-11.0 mg/ day, and 0. 35-11.36,0.88-12.90 , and 0.35-9.48 mgfL. Operating the column at 60-65 #{176}C usually shortens the useful life of the column, but this is necessary to separate the analytes from interfering peaks. We have analyzed at least 300 urine samples without having to re-pack the column.
This liquid-chromatographic method for urinary VMA, HVA, and 5-HIAA by direct urine injection is very simple, rapid, and reproducible. Values agree completely with those obtained for solvent-extracted samples. By the use of autosamplers and an automated data-computation system, this method could be used in routine screening for patients with neuroblastoma, pheochromocytoma, or carcinoid syndrome. 4. Refshage C, Kissinger P, Dreiling R, et al. New high perform-CLIN. CHEM. 29/5, 878-881 (1983) ance liquid chromatographic analysis of brain catecholamine. Life Sci 14, 311-322 (1974 907-909 (1980) .
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